1. Home
  2. BLRX vs MNY Comparison

BLRX vs MNY Comparison

Compare BLRX & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • MNY
  • Stock Information
  • Founded
  • BLRX 2003
  • MNY 2014
  • Country
  • BLRX Israel
  • MNY Singapore
  • Employees
  • BLRX N/A
  • MNY N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • MNY
  • Sector
  • BLRX Health Care
  • MNY
  • Exchange
  • BLRX Nasdaq
  • MNY Nasdaq
  • Market Cap
  • BLRX 54.1M
  • MNY 46.3M
  • IPO Year
  • BLRX 2011
  • MNY N/A
  • Fundamental
  • Price
  • BLRX $0.49
  • MNY $1.11
  • Analyst Decision
  • BLRX Strong Buy
  • MNY
  • Analyst Count
  • BLRX 2
  • MNY 0
  • Target Price
  • BLRX $11.50
  • MNY N/A
  • AVG Volume (30 Days)
  • BLRX 320.6K
  • MNY 243.5K
  • Earning Date
  • BLRX 11-18-2024
  • MNY 12-04-2024
  • Dividend Yield
  • BLRX N/A
  • MNY N/A
  • EPS Growth
  • BLRX N/A
  • MNY N/A
  • EPS
  • BLRX N/A
  • MNY N/A
  • Revenue
  • BLRX $17,048,000.00
  • MNY $88,967,081.00
  • Revenue This Year
  • BLRX N/A
  • MNY $35.91
  • Revenue Next Year
  • BLRX N/A
  • MNY $23.67
  • P/E Ratio
  • BLRX N/A
  • MNY N/A
  • Revenue Growth
  • BLRX N/A
  • MNY 28.08
  • 52 Week Low
  • BLRX $0.43
  • MNY $0.74
  • 52 Week High
  • BLRX $1.93
  • MNY $6.00
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 34.05
  • MNY 48.04
  • Support Level
  • BLRX $0.43
  • MNY $0.99
  • Resistance Level
  • BLRX $0.56
  • MNY $1.13
  • Average True Range (ATR)
  • BLRX 0.05
  • MNY 0.07
  • MACD
  • BLRX -0.01
  • MNY 0.01
  • Stochastic Oscillator
  • BLRX 23.96
  • MNY 45.53

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.

Share on Social Networks: